Do you hold BTK inhibitors in patients admitted with medical or surgical problems?

What would be your threshold to hold and/or resume them?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

What are your top takeaways in Lymphoma from ASH 2025?

What is your preferred 1L treatment for newly diagnosed Del(17p)/TP53 mutation, high-risk CLL?

How do you determine the optimal duration for 1L doublet treatment in newly diagnosed High-Risk CLL?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.